Table 1.

Participants’ anthropometric data.

	Healthy controls (n = 8)	RPD patients (n = 8)
Age (years)	60.8 ± 9.1	73.1 ± 5.7
Follow-up (months)	58.9 ± 1.3	60.4 ± 2.1
Axial length (mm)	23.56 ± 0.7	23.56 ± 0.3
BCVA(LogMAR; [Snellen]) baseline	0.0 ± 0.0 (6/6)	0.0 ± 0.0 (6/6)
BCVA(LogMAR; [Snellen]) follow-up	0.0 ± 0.0 (6/6)	0.32 ± 0.2 (6/12)
Late-stage AMD at follow-up	n/a	5 (62.5%)

Data are means ± SD or n (%).

BCVA best corrected visual acuity.